Moolec Science (MLEC) Debt Ratio (2023 - 2025)
Moolec Science (MLEC) reported Debt Ratio of 1.12 for Q2 2025, up 193.3% on a YoY basis from 0.38 in Q2 2024, and up 80.96% sequentially from 0.62 in Q4 2024.
Moolec Science (MLEC) Debt Ratio (2023 - 2025) Analysis & Trends
Moolec Science (MLEC) has 3 years of Debt Ratio data on file, last reported at 1.12 in Q2 2025.
- For the quarter ending Q2 2025, Debt Ratio rose 193.3% year-over-year to 1.12; the trailing twelve-month figure through Jun 2025 stood at 1.12 (up 193.3% YoY), and the FY2025 full-year result was 1.12, up 193.3% from the prior year.
- Debt Ratio rose to 1.12 in Q2 2025, from 0.62 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 1.12 in Q2 2025 to a low of 0.11 in Q3 2023.
- A 3-year average of 0.51 and a median of 0.56 in 2024 frame the typical range for Debt Ratio.
- Peak annual rise in Debt Ratio reached 426.15% in 2024, while the deepest fall reached 36.97% in 2024.
- Tracing MLEC's Debt Ratio over 3 years: stood at 0.63 in 2023, then declined by 2.24% to 0.62 in 2024, then surged by 80.96% to 1.12 in 2025.
- Business Quant data shows MLEC's Debt Ratio at 1.12 in Q2 2025, 0.62 in Q4 2024, and 0.56 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.12 |
| Dec 31, 2024 | 0.62 |
| Sep 30, 2024 | 0.56 |
| Jun 30, 2024 | 0.38 |
| Mar 31, 2024 | 0.41 |
| Dec 31, 2023 | 0.63 |
| Sep 30, 2023 | 0.11 |
| Jun 30, 2023 | 0.60 |
| Mar 31, 2023 | 0.17 |